Base Pair Biotechnologies receives NIH grant to develop point-of-care tests for opioids in newborns

Base Pair Biotechnologies, Inc., the Aptamer Discovery Company, announced today the receipt of a Fast Track Small Business Innovation Research grant from the National Institute on Drug Abuse of the National Institutes of Health.
Read More


>>Hollywood's Exotic Secret For Healthy Weight Loss

0 Response to "Base Pair Biotechnologies receives NIH grant to develop point-of-care tests for opioids in newborns"

Post a Comment